These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18062339)

  • 1. [Diabetes mellitus type 1. Is cognitive function influenced by treatment?].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2007 Nov; 30(11):424-5. PubMed ID: 18062339
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues.
    Alcolado J; Poole CD; Peters JR; Currie CJ
    Diabet Med; 2008 Jan; 25(1):115-6. PubMed ID: 18199142
    [No Abstract]   [Full Text] [Related]  

  • 4. Addressing insulin resistance in Type 1 diabetes.
    Pang TT; Narendran P
    Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study: response to Porcellati et al.
    Banarer S
    Diabetes Care; 2008 Mar; 31(3):e16; author reply e17. PubMed ID: 18308679
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive assessment in diabetes: the need for consensus.
    Strachan MW; Frier BM; Deary IJ
    Diabet Med; 1997 Jun; 14(6):421-2. PubMed ID: 9212305
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensive therapy of type 2 diabetes (ACCORD trial) (OCTOBER 2008).
    Drake JW
    Cleve Clin J Med; 2009 Feb; 76(2):83; author reply 83-4. PubMed ID: 19188471
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment intensification in patients with type 2 diabetes.
    Barnett AH
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():iii. PubMed ID: 18435667
    [No Abstract]   [Full Text] [Related]  

  • 10. DiaPep277 (DeveloGen).
    Giannoukakis N
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1043-50. PubMed ID: 16259226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom.
    Havas S
    Arch Intern Med; 2009 Jan; 169(2):150-4. PubMed ID: 19171811
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive therapy of type 2 diabetes (ACCORD trial) (OCTOBER 2008).
    Najman DM
    Cleve Clin J Med; 2009 Feb; 76(2):83; author reply 83-4. PubMed ID: 19188472
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuro-cognitive performance in children with type 1 diabetes--a meta-analysis.
    Naguib JM; Kulinskaya E; Lomax CL; Garralda ME
    J Pediatr Psychol; 2009 Apr; 34(3):271-82. PubMed ID: 18635605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypoglycemic agents on patients with diabetes.
    Yudkin JS; Smits P
    Circulation; 1997 Nov; 96(10):3797-8. PubMed ID: 9396501
    [No Abstract]   [Full Text] [Related]  

  • 16. Glargine in pregnant patients with Type 1 diabetes.
    Tahrani AA; Varughese GI; Wilkins JD; Taylor SE; Hanna FW
    Diabet Med; 2008 Jan; 25(1):111-2. PubMed ID: 18199139
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of new diabetes treatment trials: should current clinical practice be altered?
    Kravetz JD; Federman DG
    Postgrad Med; 2009 May; 121(3):67-72. PubMed ID: 19491542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on systemic management of diabetes.
    Masharani U; Rushakoff RJ
    Int Ophthalmol Clin; 2009; 49(2):13-33. PubMed ID: 19349784
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
    Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
    J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 2 diabetes: explosive issues in routine care].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):20. PubMed ID: 19938775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.